InvestorsHub Logo
icon url

HyGro

02/24/22 9:39 AM

#204454 RE: misiu143 #204450

But yet the CD12 CoV Severe/Critical clinical trial showed that LL had no better mortality benefit than saline solution. And yet the CD10 trial had no additional benefit from LL. NP just manipulated the data so he could claim that NEWS2 endpoint was met -- it was fraud.

icon url

ClosetInvestor

02/24/22 9:43 AM

#204455 RE: misiu143 #204450

“Previous CEO of the CYDY made a statement 5 months ago , when study show that in a critical patients mortality benefit of leronlimab ABOVE these approved toxic SOC drugs was 78% at 7 days, and 82% at 14 days..
Yes this is EFFECTIVE...and the best in the world too.. “

All wrong. CD12 was a complete failure as explained by the FDA after their review of the data. The former CEO caused the failure by focusing on the stock price and promoters instead of protocol development.

The Brazil trials could be the savior for CYDY as those were planned much better.
icon url

Emergcy

02/24/22 3:37 PM

#204490 RE: misiu143 #204450

Thanks, great post!
icon url

Marksch1

02/24/22 5:21 PM

#204499 RE: misiu143 #204450

So true misiu. Anybody with half a brain can see whats going on here. If it was my company and the Brazil numbers were good, I'd tell the FDA to pound salt. Then I would spend some bucks on tv spots exposing their shenanigans and BS, and I would do my absolute best to make sure the families of the million deceased Americans knew exactly what happened and why their beloved family member had to die.